Here are relevant reports on : clinical-documentation-improvement-market
-
Laboratoray Centrifuges Market by Product [Equipment (Microcentrifuge, Ultracentrifuge), Accessories (Tube, Plate)], Platform (Benchtop), Rotor Design (Swinging-bucket), Intended Use (Clinical), Application (Diagnostics), End User (Hospitals) - Global Forecast to 2030
The global laboratory centrifuges market, valued at US$1.53 billion in 2024, stood at US$1.58 billion in 2025 and is projected to advance at a resilient CAGR of 2.8% from 2024 to 2030, culminating in a forecasted valuation of US$1.86 billion by the end of the period. This growth is driven by increased R&D investments and research grants, technological advancements and innovative rotor designs, a rise in infectious diseases that boosts sample testing and cell-based research, and expanding applications of these centrifuges.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service (Analyzer, Sorter, Consumables, Software), Application (Research, (Clinical- Cancer, Hematology), Industrial), End User (Biotech, Hospitals) - Forecast to 2027
The latin american flow cytometry market size is projected to reach USD 379 million by 2027, at a CAGR of 7.1% during the forecast period. Key players in this market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Miltenyi Biotec GmbH (Germany), Cytek Biosciences, Inc. (US), and Luminex Corporation (US).
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Neuromarketing Tools, Technologies, & Services Market by Tool (Hardware Solution, Software Platform), Technology (EEG & Brainware Monitoring, Biometric & Physiological Monitoring), End Users (Clinical Research, Consumer Research) - Global Forecast to 2030
The neuromarketing tools, technologies, and services market is segmented by tools (hardware solutions like EEG amplifiers, eye-tracking, biometric devices, and software platforms), technologies (EEG & brainwave monitoring, eye-tracking, biometric & physiological monitoring), and end users (commercial & enterprise solutions, consumer research, academic & clinical research, and others). Market estimates are derived through extensive secondary and primary research, applying top-down and bottom-up approaches with data triangulation. The study covers global and regional market dynamics, competitive landscape, and forecasts up to 2030, profiling key players such as Tobii AB, iMotions, EMOTIV, Brain Products, Smart Eye, and others.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Chemistry Analyzers Market by Product [Analyzers (Fully Automated, PoC, Semi-automated), Reagents], Test Type [Lipid Profile, Liver, Basic Metabolic Panels], End User [Hospitals & Clinics, Research, Labs], Region - Global Forecast to 2030
The global clinical chemistry analyzers market, valued at US$15.23 billion in 2024, stood at US$15.92 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$20.86 billion by the end of the period. The growing adoption of point-of-care testing and laboratory automation is also supporting market expansion across healthcare settings.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Gene Expression Analysis Market by Product (Reagents, Enzymes, Kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & Development, Clinical Diagnostics), End User & Region - Global Forecast to 2029
The global gene expression analysis market, valued at US$3.9 billion in 2023, stood at US$4.2 billion in 2024 and is projected to advance at a resilient CAGR of 8.1% from 2024 to 2029, culminating in a forecasted valuation of US$6.2 billion by the end of the period. Growth in this market is primarily driven by the increasing investments by pharmaceutical & biotechnology companies for genome based studies.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
RTD Protein Beverages Market, By Source (Milk, whey, Casein, Egg, Soy, Rice), By Types (Weight Management Drinks, Clinical Drinks, Energy Drinks, Juice Drinks) - Trends & Forecast to 2018
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application (Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029
The global 3D bioprinting market, valued at US$1.2 billion in 2023, stood at US$1.3 billion in 2024 and is projected to advance at a resilient CAGR of 12.7% from 2024 to 2029, culminating in a forecasted valuation of US$2.4 billion by the end of the period. The market growth is fueled by the growing adoption of 3D bioprinting technology in the pharmaceutical and cosmetic industries, technological advancements in 3D bioprinting, and the rising demand for organ transplants.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Computer Assisted Coding Market by Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), Application (Automated Encoding, Clinical Coding Audit, Management Reporting) - Global Forecast to 2022
The global computer-assisted coding market is valued at USD 2.76 Billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 Billion by 2022. In 2016, 3M Company (U.S.) and Optum, Inc. (U.S.) dominated the global computer-assisted coding market. Some of the prominent players in the market are Nuance Communications, Inc. (U.S.), Cerner Corporation (U.S.) and Artificial Medical Intelligence, Inc. (U.S.). Some of the other leading players in this market are Dolbey Systems, Inc. (U.S.), Precyse Solutions, LLC (U.S.), Craneware plc (U.K.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Streamline Health Solutions, Inc. (U.S.), MMODAL IP LLC (M*Modal) (U.S.), TruCode (U.S.), Quest Diagnostics Inc. (U.S.), and Epic Systems Corporation(U.S.).
- Published: July 2017
- Price: $ 4950
- TOC Available:
-
Clinical Trial Supplies Market by Services (Manufacturing, Sourcing, Packaging, Labelling, Logistics), Phases, Type (Small Molecules, Biologics, Vaccines), Therapeutic Areas (Oncology, Neurology, CVD, Ophthalmology, Dermatology) - Global Forecast to 2030
The global clinical trial supplies market, valued at US$4.85 billion in 2024, stood at US$5.34 billion in 2025 and is projected to advance at a resilient CAGR of 8.9% from 2025 to 2030, culminating in a forecasted valuation of US$8.18 billion by the end of the period. The growing complexity of clinical trials, particularly with decentralized and adaptive trial designs, has heightened the demand for efficient supply chain management solutions.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031
The global autoimmunity diagnostics market, valued at US$5.26 billion in 2024, stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmunity diagnostics market is consistently growing, fueled by several key factors. These include the rising prevalence of autoimmune disease, growing awareness about early and accurate diagnosis, increasing research activities, and rapid advancements in diagnostic technologies.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
